- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

Can Sirolimus Injections Prevent Vision Loss in Patients With Geographic Atrophy From Dry Macular Degeneration?

Posted By Dr. Ari Weitzner On October 10, 2011 @ 5:22 am In Clinical Trials,Macular Degeneration,Research,Retina | No Comments

Dry macular degeneration involves a constellation of clinical features that can include drusen, pigment clumping and/or retinal pigment epithelium (RPE) dropout and geographic atrophy (GA). GA can begin as a thinning of the RPE with involvement of the underlying choriocapillaris and subsequently lead to an atrophic change in the macula. Inflammation may play a role in the pathogenesis of GA.

Sirolimus inhibits the production, signaling and activity of many inflammatory factors relevant to the development of GA.

The objective of a clinical trial now being underway at the National Institutes of Health Clinical Center will investigate the safety and possible efficacy of serial sirolimus intravitreal injections to prevent vision loss in patients with GA.

Click here [1] for further details.


Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/006135-can-sirolimus-injections-prevent-vision-loss-in-patients-with-geograhic-atrophy-resulting-from-dry-macular-degeneration/

URLs in this post:

[1] Click here: http://www.clinicaltrials.gov/ct2/show/NCT01445548?term=eye+disease+%5BDISEASE%5D+AND+%28+%2206%2F18%2F2011%22+%3A+MAX+%29+%5BFIRST-RECEIVED-DATE%5D&recr=Open&no_unk=Y&rcv_d=14

Copyright © 2008 Eye Doc Talk. All rights reserved.